Nanoparticles can turn off genes in bone marrow

Researchers from Penn Engineering and MIT have developed a way to turn off specific genes in cells of bone marrow, which play an important role in producing blood cells. 

Using specialized nanoparticles, researchers from Penn Engineering and the Massachusetts Institute of Technology have developed a way to turn off specific genes in cells of bone marrow, which play an important role in producing blood cells. These particles could be tailored to help treat heart disease or to boost the yield of stem cells in patients who need stem cell transplants.

Microscopic view of  lung cells expressing the synthetic mRNA
Nanoparticles delivering messenger RNA to specific organs. (Image: Penn Engineering Today)

This type of genetic therapy, known as RNA interference, is usually difficult to target to organs other than the liver, where nanoparticles would tend to accumulate. The researchers were able to modify their particles in such a way that they would accumulate in the cells found in the bone marrow.

In a recent Nature Biomedical Engineering study, conducted in mice, the researchers showed that they could use this approach to improve recovery after a heart attack by inhibiting the release of bone marrow blood cells that promote inflammation and contribute to heart disease.

“If we can get these particles to hit other organs of interest, there could be a broader range of disease applications to explore, and one that we were really interested in in this paper was the bone marrow. The bone marrow is a site for hematopoiesis of blood cells, and these give rise to a whole lineage of cells that contribute to various types of diseases,” says Michael Mitchell, Skirkanich assistant professor of innovation in Penn Engineering’s Department of Bioengineering, one of the lead authors of the study.

Read more at Penn Engineering Today.